ScientiaBio, a provider of cutting edge quality service & training in Clinical Research and Computational Biology was established in March, 2010. Our mission is to strengthen an organization's overall productivity by empowering its people via knowledge transfer. We have successfully established our training across India and few others pharma emerging nations within very short span of time. We continue to focus on our objective and very soon we are going to establish our footprint across all pharma emerging nations.
Average growth time of a small molecule medicine from early phase R&D to commercialization in market is approximately varies from 10 to 15 years. Drug discovery is an expensive, slow and risky business. The rate of failure is still very high. The scope of better success rate depends on many factors. One of the primary factor is to understand the practical problem in each phase of drug discovery & development and finding solution for them.
Drug Discovery and Development